2013;70:398C411. internationalen Literatur entwickelten pass away Mitglieder der beteiligten Fachgesellschaften in einem formellen Prozess Mouse monoclonal to CD95(FITC) einen Konsensus. Empfehlungen und Statements der Leitlinie wurden in einem formalen Prozess (DELPHI-Prozess, Konsenstreffen mit moderiertem Abstimmungsprozess) erarbeitet und konsentiert. Empfehlungen Sera wurden Empfehlungen zur Diagnostik und Therapie von Paaren mit WSA anhand der internationalen Literatur erarbeitet. Insbesondere wurde auf pass away bekannten Risikofaktoren wie chromosomale, anatomische, endokrinologische, gerinnungsphysiologische, psychologische, infektiologische und immunologische St?rungen eingegangen. Schlsselw?rter: wiederholter Spontanabort, Inzidenz, Diagnose, Therapie, Empfehlungen I? Guideline Information Guidelines system of the DGGG, OEGGG and SGGG Info on the guidelines system is definitely available at the end of the guideline. Citation format Recurrent miscarriage: SSTR5 antagonist 2 diagnostic and restorative procedures. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry Quantity 015/050). Geburtsh Frauenheilk 2018; 78: 364C381 Guideline documents The complete long version, a short version, a PDF slideshow for PowerPoint presentations and a summary of the conflicts of interest of all the authors are available in German within the AWMF homepage under: http://www.awmf.org/leitlinien/detail/ll/015-050.html Guideline authors See Table 1 . SSTR5 antagonist 2 Table 1 ?The following professional and scientific societies/working groups/organisations/associations have stated their desire for contributing to the compilation of the guideline text and participating in the consensus conference and nominated representatives to attend the consensus conference.
Lead author and coordinating author: Prof. Dr. Bettina TothAustrian Society of Gynecology and Obstetrics (?sterreichische Gesellschaft fr Gyn?kologie und Geburtshilfe [OEGGG])German Society of Gynecology and Obstetrics (Deutsche Gesellschaft fr Gyn?kologie und Geburtshilfe e.?V. [DGGG])German Society for Gynecologic Endocrinology and Reproductive Medicine (Gesellschaft fr Gyn?kologische Endokrinologie und Fortpflanzungsmedizin [DGGEF])Prof. Dr. Clemens TempferGerman Society of Gynecology and Obstetrics (DGGG) Additional lead authors: Prof. Dr. Wolfgang WrfelGerman Society of Gynecology and Obstetrics (DGGG)German Society for Gynecologic Endocrinology and Reproductive Medicine (DGGEF)Prof. Dr. M. BohlmannGerman Society of Gynecology and Obstetrics (DGGG)Working Group Immunology in the DGGG (Arbeitsgemeinschaft Immunologie in der DGGG [AGIM])Prof. Dr. J. ZschockeGerman Society of Human being Genetics (Deutsche Gesellschaft fr Humangenetik e.?V. [GfH])Prof. Dr. S. Rudnik-Sch?nebornGerman Society of Human being Genetics (GfH)Prof. Dr. E. Schleu?nerGerman Society of Ultrasound in Medicine (Deutsche Gesellschaft fr Ultraschall in der Medizin e.?V. [DEGUM])PD Dr. N. RogenhoferWorking Group Immunology in the DGGG (AGIM)Prof. Dr. T. WischmannGerman Society for Fertility Counselling (Deutsche Gesellschaft fr Kinderwunschberatung [BKiD])Prof. Dr. M.?von WolffSwiss Society of Gynecology and Obstetrics (Schweizerische Gesellschaft fr Gyn?kologie und Geburtshilfe [SGGG])Prof. Dr. K. HanckeGerman Society of Reproductive Medicine (Deutsche Gesellschaft fr Reproduktionsmedizin [DGRM])PD Dr. S. von OtteProfessional Association of Gynecologists (Berufsverband der Frauen?rzte [BVF]) Open in a separate windows AbbreviationsAbantibodiesANAantinuclear antibodiesaPLantiphospholipidAPSantiphospholipid syndromeASAacetylsalicylic acidASRMAmerican Society for Reproductive MedicineFVLfactor V LeidenG-CSFgranulocyte colony-stimulating factorGM-CSFgranulocyte-macrophage colony-stimulating factorGWweek of gestationHLAhuman leukocyte antigenIVIGintravenous immunoglobulinLBRlive birth rateLITlymphocyte immunization therapyLMWHlow-molecular-weight heparinNKnatural killerPCOpolycystic ovariesPGDpreimplantation genetic diagnosisRCOGRoyal College of Obstetricians and GynaecologistsRMrecurrent miscarriagePTprothrombinSGAsmall for gestational ages/pstatus postTPOthyroid peroxidaseTSHthyroid-stimulating hormoneVTE venous thromboembolism ? II? Guideline Software Purpose and objectives The aim of this guideline is definitely to standardize the analysis and treatment SSTR5 antagonist 2 of couples with recurrent miscarriage (RM) based on the most current national and international literature. Targeted areas of individual care Outpatient and/or inpatient care. Target user organizations/target target audience The recommendations of the guideline are resolved to gynecologists and their colleagues working in medical fields such as human being genetics, psychotherapy, laboratory medicine, hemostasis, internal and general medicine and additional SSTR5 antagonist 2 professional staff involved in the care and attention of individuals with RM. Targeted individual group: couples with RM Adoption of the guideline and period of validity The validity of this guideline was confirmed from the respective boards/representatives of the participating professional medical societies, working organizations, organizations and associations, by the table of the DGGG, SGGG and OEGGG and the DGGG/OEGGG/SGGG Guideline Percentage.